Imperva Inc (IMPV) Receives Consensus Rating of “Hold” from Analysts

Shares of Imperva Inc (NASDAQ:IMPV) have earned a consensus recommendation of “Hold” from the twenty-one research firms that are presently covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a sell recommendation, seven have given a hold recommendation, nine have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $51.86.

IMPV has been the subject of a number of recent analyst reports. BidaskClub upgraded Imperva from a “sell” rating to a “hold” rating in a report on Tuesday, September 12th. Zacks Investment Research downgraded Imperva from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 27th. Wells Fargo & Co downgraded Imperva from an “outperform” rating to a “market perform” rating in a report on Monday, October 9th. William Blair downgraded Imperva from an “outperform” rating to a “market perform” rating in a report on Tuesday, October 10th. Finally, Imperial Capital decreased their price target on Imperva from $57.00 to $50.00 and set an “outperform” rating for the company in a report on Tuesday, October 10th.

Several institutional investors and hedge funds have recently modified their holdings of the company. Van ECK Associates Corp grew its stake in shares of Imperva by 0.8% in the 2nd quarter. Van ECK Associates Corp now owns 8,346 shares of the software maker’s stock valued at $399,000 after buying an additional 64 shares during the period. Comerica Bank grew its stake in shares of Imperva by 0.8% in the 2nd quarter. Comerica Bank now owns 19,707 shares of the software maker’s stock valued at $978,000 after buying an additional 157 shares during the period. Ameritas Investment Partners Inc. grew its stake in shares of Imperva by 18.7% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,940 shares of the software maker’s stock valued at $141,000 after buying an additional 464 shares during the period. Parametric Portfolio Associates LLC lifted its position in Imperva by 5.3% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 11,614 shares of the software maker’s stock valued at $556,000 after acquiring an additional 581 shares in the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. lifted its position in Imperva by 26.2% in the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 4,177 shares of the software maker’s stock valued at $201,000 after acquiring an additional 866 shares in the last quarter. Institutional investors own 96.93% of the company’s stock.

Imperva (IMPV) traded up $0.20 during midday trading on Monday, reaching $42.30. The company had a trading volume of 316,216 shares, compared to its average volume of 297,560. The firm has a market capitalization of $1,440.00, a P/E ratio of 156.67 and a beta of 1.78. Imperva has a 1-year low of $37.17 and a 1-year high of $52.40.

Imperva (NASDAQ:IMPV) last posted its quarterly earnings data on Wednesday, November 8th. The software maker reported $0.33 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.22 by $0.11. The business had revenue of $83.89 million during the quarter, compared to the consensus estimate of $83.79 million. Imperva had a negative return on equity of 8.52% and a net margin of 3.04%. Imperva’s quarterly revenue was up 22.6% on a year-over-year basis. During the same period in the prior year, the business posted $0.08 earnings per share. research analysts forecast that Imperva will post -0.52 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This report was first reported by American Banking News and is owned by of American Banking News. If you are reading this report on another site, it was copied illegally and reposted in violation of United States & international trademark & copyright laws. The correct version of this report can be viewed at https://www.americanbankingnews.com/2018/01/08/imperva-inc-impv-receives-consensus-rating-of-hold-from-analysts.html.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NASDAQ:IMPV)

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply